Effect of maternal PCOS and PCOS-like phenotype on the offspring's health
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder with both reproductive and metabolic abnormalities affecting women of reproductive age. While the exact origin of PCOS is unknown, observations from clinical and animal studies suggest that maternal hyperandrogenism may be a contributing factor. Because women with PCOS manifest hyperandrogenism during pregnancy, changes in the gestational endocrine milieu may play a role in the vertical transmission of this syndrome. This review discusses the potential developmental origins of PCOS, the impact of maternal PCOS on the offspring’s health and contributions of the postnatal environment, capitalizing on findings from animal models that exhibit a PCOS-like phenotype. In addition, this review highlights the scarcity of data at early gestational stages in humans and the importance of animal experimentation to better understand the cellular and molecular mechanisms involved in the programming of adult diseases, therefore, helping identify therapeutic targets for preventive and treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 2×
“The heterogeneity of the phenotypic expression of PCOS has led to numerous consensus meetings aimed at defining guidelines to aid in diagnosis and clinical care of this syndrome (Fauser et al., 2012).”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Disclosure statement: The authors have nothing to disclose anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript (T2DM) and cardiovascular diseases (Diamanti-Kandarakis and Dunaif, 2012, Moran et al., 2015).”
BackgroundThe Developmental Origins of Adult Disease
Barker, D. J. P. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719428 · Cited by 1,854
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · cited 1×
“Such association was not evident with other gene loci either due to small sample size, varied diagnostic criteria, or phenotypic heterogeneity (Goodarzi et al., 2011a, McAllister et al., 2015).”
BackgroundMorishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416 · cited 2×
“, 1994), and loss of function mutations in aromatase (Morishima et al., 1995) or sex hormonebinding globulin gene (SHBG) (Hogeveen et al.”
BackgroundDumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782 · cited 6×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Gene Name Gene Symbol Cohort Approach Reference Small Glutamine-rich Tetratricopeptide-containing protein Alpha SGTA American Caucasian Genotyping Ewens et al., 2010 RAB5B, member RAS oncogene family RAB5B Han Chinese GWAS Shi et al., 2012…”
BackgroundInfluentialEvidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678 · cited 9×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Gene Name Gene Symbol Cohort Approach Reference Small Glutamine-rich Tetratricopeptide-containing protein Alpha SGTA American Caucasian Genotyping Ewens et al., 2010 RAB5B, member RAS oncogene family RAB5B Han Chinese GWAS Shi et al., 2012…”
BackgroundInfluentialThe polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Heritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555 · cited 1×
“Prenatally testosterone treated female rhesus monkeys have been shown to manifest hyperandrogenism and LH hypersecretion during the infantile development, suggesting that these may be endocrine antecedents of the adult PCOS-like phenotype (Abbott et al., 2005, Eisner et al., 2002).”
BackgroundBisphenol A and Reproductive Health: Update of Experimental and Human Evidence, 2007–2013
Peretz, J., Vrooman, L., Ricke, W. A., Hunt, P. A., Ehrlich, S., Hauser, R., Padmanabhan, V., Taylor, H. S., Swan, S. H., VandeVoort, C. A., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307728 · Cited by 555
Self-citationGonzález, F. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.003 · Cited by 515 · cited 1×
“Additionally, obesity and associated hyperglycemia can increase adipose tissue oxidative stress, mononuclear cell infiltration, and promote chronic low-grade inflammation with increased cytokines production (Gonzalez, 2012, Gonzalez et al., 2005).”
BackgroundHayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478 · cited 4×
“…YAP1 Han Chinese GWAS Li et al., 2012 North European Genotyping Louwers et al., 2013 Follicle-stimulating hormone beta FSHB American Caucasian GWAS Hayes et al., 2015 Day et al., 2015 Fibrillin 3 FBN3 Majority of EuropeanOrigin Genotyping Ewens et al., 2010, Urbanek et al., 2005 Chromosome 9 open…”
BackgroundInfluentialDay, F. R., Hinds, D. A., Tung, J. Y., Stolk, L., Styrkarsdottir, U., Saxena, R., Bjonnes, A., Broer, L., Dunger, D. B., Halldorsson, B. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9464 · Cited by 459 · cited 9×
“…Li et al., 2012 North European Genotyping Louwers et al., 2013 Follicle-stimulating hormone beta FSHB American Caucasian GWAS Hayes et al., 2015 Day et al., 2015 Fibrillin 3 FBN3 Majority of EuropeanOrigin Genotyping Ewens et al., 2010, Urbanek et al., 2005 Chromosome 9 open reading frame 3…”
BackgroundInfluentialImpact of Obesity on the Risk for Polycystic Ovary Syndrome
Yildiz, B. O., Knochenhauer, E. S., & Azziz, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1834 · Cited by 401 · cited 1×
“This could arise because adipose tissue increases androgen and suppresses SHBG production leading to hyperandrogenism (Yildiz et al., 2008).”
BackgroundBayer, T. A., Falkai, P., & Maier, W. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00039-4 · Cited by 346 · cited 1×
“…has been proposed to explain the pathogenesis of neurodegenerative diseases and cancer, suggesting that a series of insults that alone are insufficient to lead to disease may be necessary for the development, manifestation, and progression of these disorders (Bayer et al., 1999, Tang et al., 2008).”
BackgroundQin, J. Z., Pang, L. H., Li, M. J., Fan, X. J., Huang, R. D., & Chen, H. Y. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-56 · Cited by 317 · cited 1×
“…studies have shown that offspring of PCOS mothers are at higher risk for preterm birth, perinatal mortality, congenital abnormalities, increased hospitalization for metabolic disorders, diseases of nervous system, and asthma (Boomsma et al., 2006, Doherty et al., 2015, Qin et al., 2013).”
BackgroundNonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304 · cited 5×
“This is particularly evident in patients with CAH where prenatal androgenization could lead to development of adult onset of PCOS in the offspring (Barnes et al., 1994).”
BackgroundInfluentialSir-Petermann, T., Codner, E., Pérez, V., Echiburú, B., Maliqueo, M., Ladrón de Guevara, A., Preisler, J., Crisosto, N., Sánchez, F., Cassorla, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2836 · Cited by 260 · cited 4×
“Moreover, while alterations in the prenatal (Sir-Petermann et al., 2002) and postnatal environments (Sir-Petermann et al., 2009, Sir-Petermann et al., 2007b, SirPetermann et al., 2007a) have been reported in daughters of PCOS women, the scarcity of longitudinal studies in these individuals prevents…”
BackgroundInfluentialMetabolic risk in PCOS: Phenotype and adiposity impact
Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.12.003 · Cited by 245
Reproductive consequences of developmental phytoestrogen exposure
Jefferson, W. N., Patisaul, H. B., & Williams, C. J. (2012) · Reproduction · doi:10.1530/rep-11-0369 · Cited by 181 · cited 1×
“…changes in the expression of steroid receptors, and/or via exposure to environmental compounds with steroid-like structure (e.g. phytoestrogens, industrial byproducts, and pesticides) (Gore, 2008, Bahrke et al., 1998, Smithells, 1981, Levin et al., 1991, New, 2006, Jefferson et al., 2012).”
BackgroundAbbott, D. H., Tarantal, A. F., & Dumesic, D. A. (2009) · American Journal of Primatology · doi:10.1002/ajp.20679 · Cited by 177 · cited 4×
“, 2008a), they manifest a greater body weight gain during the infantile and juvenile development (Abbott et al., 2009).”
BackgroundInfluentialHAGUE, W. M., ADAMS, J., RODDA, C., BROOK, C. G. D., DE BRUYN, R., GRANT, D. B., & JACOBS, H. S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03887.x · Cited by 175
Xu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155 · cited 2×
“…global methylation of peripheral blood DNA was not significantly altered in women with PCOS (Xu et al., 2010), this does not rule out tissue-specific changes as observed in the adipose tissue of prenatally androgenized rhesus macaques (Xu et al., 2011) and women with PCOS (Jones et al., 2015).”
BackgroundAndrogens before and after Weight Loss in Obese Children
Reinehr, T., de Sousa, G., Roth, C. L., & Andler, W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0438 · Cited by 149 · cited 7×
“Because weight loss is accompanied by a reduction in circulating concentrations of androgens in prepubertal girls (Reinehr et al., 2005), weight management represents an important preventive strategy for obese and overweight patients.”
BackgroundInfluentialPalomba, S., Marotta, R., Di Cello, A., Russo, T., Falbo, A., Orio, F., Tolino, A., Zullo, F., Esposito, R., & Sala, G. B. L. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04443.x · Cited by 144 · cited 2×
“One study found elevated second trimester amniotic fluid concentrations of testosterone in pregnant PCOS women (Palomba et al., 2012a).”
BackgroundHuman sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction
Hogeveen, K. N., Cousin, P., Pugeat, M., Dewailly, D., Soudan, B., & Hammond, G. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214060 · Cited by 107
de Melo, A. S., Dias, S. V., Cavalli, R. D. C., Cardoso, V. C., Bettiol, H., Barbieri, M. A., Ferriani, R. A., & Vieira, C. S. (2015) · Reproduction · doi:10.1530/rep-14-0499 · Cited by 99 · cited 1×
“However, women born appropriate for gestational age can also develop PCOS, suggesting a multifactorial etiology (de Melo et al., 2015).”
BackgroundFetal origins of the metabolic syndrome
Xita, N., & Tsatsoulis, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05658.x · Cited by 96 · cited 5×
“Inappropriate exposure during development to steroids or EDCs can also induce epigenetic alterations and influence the development and severity of many adult onset diseases (Li and Huang, 2008, Xita and Tsatsoulis, 2010).”
BackgroundInfluentialUterine effects of metformin administration in anovulatory women with polycystic ovary syndrome
Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2006) · Human Reproduction · doi:10.1093/humrep/dei351 · Cited by 85 · cited 1×
“An increase in blood flow resistance in the uterine arteries and a reduction in subendometrial and endometrial vascularity have been observed in young non-pregnant women with PCOS indicating endometrial derangements that could impair implantation and placentation (Palomba et al., 2006).”
Background
Cited by
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Self-citationDevelopmental programming, a pathway to disease
Padmanabhan, V., Cardoso, R. C., & Puttabyatappa, M. (2016) · Endocrinology · doi:10.1210/en.2016-1003 · Cited by 208
Self-citationOvarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update
Richards, J. S., Ren, Y. A., Candelaria, N., Adams, J. E., & Rajkovic, A. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00164 · Cited by 201
Metadata
- Authors
- Puttabyatappa, M., Cardoso, R. C., & Padmanabhan, V.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 435
- Pages
- 29-39
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2172472837
- Cited by
- 85
- References
- 36
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.